Therefore, developing biomarkers to predict patients at higher risk of BM might be significant in helping identify sub-groups who need early detection of BM by close observation and benefit from intensification of systemic therapy, which is crucial for improving outcomes.
← all excerpts
Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer.
1
—
—